Novel Biomarkers of Gastric Adenocarcinoma: Current Research and Future Perspectives
Overall survival of gastric cancer remains low, as patients are often diagnosed with advanced stage disease. In this review, we give an overview of current research on biomarkers in gastric cancer and their implementation in treatment strategies. The HER2-targeting trastuzumab is the first molecular...
Guardado en:
Autores principales: | Nadja Niclauss, Ines Gütgemann, Jonas Dohmen, Jörg C. Kalff, Philipp Lingohr |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d9b7fe0ecc1249cd8def507e944b250c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Proteomic profiling identifies signatures associated with progression of precancerous gastric lesions and risk of early gastric cancer
por: Xue Li, et al.
Publicado: (2021) -
ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer
por: Moghbeli,Meysam, et al.
Publicado: (2019) -
Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer
por: Ying Liu, et al.
Publicado: (2021) -
Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer
por: Ying Liu, et al.
Publicado: (2021) -
The diagnostic and prognostic value of miR-92a in gastric cancer: A systematic review and meta-analysis
por: Guo Hanxu, et al.
Publicado: (2021)